Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Homeopathic "growth factors" being targeted to AIDS patients by Biomed Comm.

This article was originally published in The Tan Sheet

Executive Summary

HOMEOPATHIC "GROWTH FACTORS" BEING MARKETED AS AIDS TREATMENTS by the Seattle, Wash.-based start-up company Biomed Comm, Inc. The company, founded in May, is taking orders for the oral drops through its Web site for delivery in January and plans to introduce the products into retail stores in the future. Biomed Comm announced Dec. 13 that it had received a U.S. patent notice of allowance for the products; Biomed claims to be the "first company to patent homeopathic growth factors for use as an alternative medicine."
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS086474

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel